09:13 AM EDT, 07/01/2024 (MT Newswires) -- Health care stocks were mixed premarket Monday as the Health Care Select Sector SPDR Fund ( XLV ) was 0.3% higher and the iShares Biotechnology ETF ( IBB ) was down 0.2% recently.

SpringWorks Therapeutics ( SWTX ) advanced by almost 4% after saying it has submitted a new-drug application to the US Food and Drug Administration for mirdametinib to treat patients with neurofibromatosis type 1- associated plexiform neurofibromas, a rare genetic disorder.

Sanofi ( SNY ) is close to deciding on an investment of between 1.3 billion euros and 1.5 billion euros ($1.40 billion to $1.61 billion) at a key production site in Frankfurt, Germany, where it manufactures insulin, German newspaper Handelsblatt reported. Sanofi ( SNY ) was up nearly 2% pre-bell.

Gene therapy manufacturer Genezen said it will acquire uniQure's (QURE) commercial gene therapy operations in Lexington, Massachusetts. uniQure was up nearly 3% premarket.